Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The Human Phenotype Ontology in 2021

Title: The Human Phenotype Ontology in 2021
Authors: Kohler S; Gargano M; Matentzoglu N; Carmody LC; Lewis-Smith D; Vasilevsky NA; Danis D; Balagura G; Baynam G; Brower AM; Callahan TJ; Chute CG; Est JL; Galer PD; Ganesan S; Griese M; Haimel M; Pazmandi J; Hanauer M; Harris NL; Hartnett MJ; Hastreiter M; Hauck F; He Y; Jeske T; Kearney H; Kindle G; Klein C; Knoflach K; Krause R; Lagorce D; McMurry JA; Miller JA; Munoz-Torres MC; Peters RL; Rapp CK; Rath AM; Rind SA; Rosenberg AZ; Segal MM; Seidel MG; Smedley D; Talmy T; Thomas Y; Wiafe SA; Xian J; Yuksel Z; Helbig I; Mungall CJ; Haendel MA; Robinson PN
Source: Nucleic Acids Research, 8 January 2021
Publisher Information: Oxford University Press
Publication Year: 2021
Collection: Newcastle University Library ePrints Service
Description: © The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.The Human Phenotype Ontology (HPO, https://hpo.jax.org) was launched in 2008 to provide a comprehensive logical standard to describe and computationally analyze phenotypic abnormalities found in human disease. The HPO is now a worldwide standard for phenotype exchange. The HPO has grown steadily since its inception due to considerable contributions from clinical experts and researchers from a diverse range of disciplines. Here, we present recent major extensions of the HPO for neurology, nephrology, immunology, pulmonology, newborn screening, and other areas. For example, the seizure subontology now reflects the International League Against Epilepsy (ILAE) guidelines and these enhancements have already shown clinical validity. We present new efforts to harmonize computational definitions of phenotypic abnormalities across the HPO and multiple phenotype ontologies used for animal models of disease. These efforts will benefit software such as Exomiser by improving the accuracy and scope of cross-species phenotype matching. The computational modeling strategy used by the HPO to define disease entities and phenotypic features and distinguish between them is explained in detail.We also report on recent efforts to translate the HPO into indigenous languages. Finally, we summarize recent advances in the use of HPO in electronic health record systems.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: unknown
Relation: https://eprints.ncl.ac.uk/272841; https://eprints.ncl.ac.uk/fulltext.aspx?url=272841/250F446C-AF7A-40EF-ABED-4E0352D7F174.pdf&pub_id=272841
Availability: https://eprints.ncl.ac.uk/272841
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.5C2B5ED4
Database: BASE